• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Another warning for CareFusion’s Alaris drug pump

December 22, 2016 By Sarah Faulkner

Another warning for CareFusion's Alaris drug pumpThe U.K.’s Medicines & Healthcare Products Regulatory Agency issued a warning today for Carefusion‘s Alaris syringe drug pumps. The UK watchdog said that Alaris pumps with broken springs in the plunger assembly could accidentally release a single dose of medication if the pump also uses non-recommended syringes.

“This problem comes about through a combination of using non-recommended syringes with a pump that has a broken spring in the syringe driver plunger housing,” the regulatory agency wrote. “To date CareFusion has not identified an increased risk of this problem when recommended syringes are used.”

Users should contact CareFusion to learn how to check the plunger holder’s springs if the pump is displaying ‘check syringe’ alarms. The regulatory group also cautioned that the pump should only be used with recommended syringes and that the syringe pumps should be regularly maintained.

Users have until January 10, 2017 to begin taking action and must be in compliance with the agency’s recommendations by February 7.

This is the latest in a series of warnings issued to CareFusion regarding its Alaris pumps over the past few years. In August 2015, the FDA issued 2 Class 1 recall notices related to the pump over alarm issues and the pump’s replacement frame membrane.

The company also initiated 2 class 1 recalls between 2013 and 2014 over software issues with the Alaris pump.

Filed Under: Drug-Device Combinations, Featured, Food & Drug Administration (FDA), Regulatory/Compliance, Wall Street Beat Tagged With: CareFusion

IN CASE YOU MISSED IT

  • Medtronic Diabetes names CFO with consumer experience ahead of separation
  • Diabeloop launches insulin delivery algorithm in Germany
  • GlucoModicum has positive data for needle-free CGM
  • Lifecare takes next steps in CGM implant development
  • Ypsomed brings autoinjector for dual GCG/GLP-1 delivery to China

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS